Atlas Capital Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $42.9K | Sell |
169
-5,960
| -97% | -$1.39M | ﹤0.01% | 749 |
|
|
2026
Q1 | $1.5M | Buy |
6,129
+360
| +6% | +$83.9K | 0.17% | 117 |
|
|
2025
Q4 | $1.19M | Buy |
+5,769
| New | +$1.14M | 0.13% | 131 |
|
|
2025
Q2 | $880K | Hold |
5,761
| – | – | 0.11% | 168 |
|
|
2025
Q1 | $955K | Hold |
5,761
| – | – | 0.12% | 149 |
|
|
2024
Q4 | $833K | Buy |
5,761
+5,700
| +9,344% | +$883K | 0.11% | 167 |
|
|
2024
Q3 | $9.88K | Sell |
61
-5,700
| -99% | -$908K | ﹤0.01% | 729 |
|
|
2024
Q2 | $842K | Buy |
5,761
+5,178
| +888% | +$770K | 0.11% | 147 |
|
|
2024
Q1 | $92.2K | Sell |
583
-5,478
| -90% | -$872K | 0.01% | 493 |
|
|
2023
Q4 | $950K | Sell |
6,061
-10
| -0.2% | -$1.53K | 0.14% | 128 |
|
|
2023
Q3 | $946K | Hold |
6,071
| – | – | 0.16% | 108 |
|
|
2023
Q2 | $1M | Buy |
6,071
+279
| +5% | +$45K | 0.15% | 109 |
|
|
2023
Q1 | $898K | Hold |
5,792
| – | – | 0.14% | 108 |
|
|
2022
Q4 | $1.02M | Hold |
5,792
| – | – | 0.17% | 104 |
|
|
2022
Q3 | $946K | Sell |
5,792
-729
| -11% | -$123K | 0.17% | 108 |
|
|
2022
Q2 | $1.16M | Hold |
6,521
| – | – | 0.2% | 97 |
|
|
2022
Q1 | $1.16M | Hold |
6,521
| – | – | 0.18% | 103 |
|
|
2021
Q4 | $1.12M | Hold |
6,521
| – | – | 0.17% | 103 |
|
|
2021
Q3 | $1.05M | Sell |
6,521
-300
| -4% | -$51.2K | 0.17% | 107 |
|
|
2021
Q2 | $1.12M | Buy |
6,821
+71
| +1% | +$11.8K | 0.19% | 108 |
|
|
2021
Q1 | $1.11M | Sell |
6,750
-50
| -0.7% | -$8.09K | 0.22% | 99 |
|
|
2020
Q4 | $1.07M | Hold |
6,800
| – | – | 0.23% | 92 |
|
|
2020
Q3 | $1.01M | Sell |
6,800
-46
| -0.7% | -$6.81K | 0.24% | 97 |
|
|
2020
Q2 | $963K | Hold |
6,846
| – | – | 0.23% | 98 |
|
|
2020
Q1 | $898K | Buy |
6,846
+1
| +0% | +$142 | 0.27% | 89 |
|
|
2019
Q4 | $999K | Sell |
6,845
-958
| -12% | -$130K | 0.25% | 106 |
|
|
2019
Q3 | $1.01M | Sell |
7,803
-10,514
| -57% | -$1.39M | 0.3% | 95 |
|
|
2019
Q2 | $2.55M | Buy |
18,317
+2,784
| +18% | +$385K | 0.84% | 17 |
|
|
2019
Q1 | $2.17M | Sell |
15,533
-1,105
| -7% | -$148K | 0.78% | 24 |
|
|
2018
Q4 | $2.15M | Buy |
16,638
+10,638
| +177% | +$1.48M | 0.86% | 20 |
|
|
2018
Q3 | $834K | Hold |
6,000
| – | – | 0.28% | 97 |
|
|
2018
Q2 | $775K | Sell |
6,000
-523
| -8% | -$65.2K | 0.28% | 105 |
|
|
2018
Q1 | $836K | Buy |
+6,523
| New | +$882K | 0.26% | 114 |
|
Other funds holding JNJ
Atlas Capital Advisors's JNJ Position: Q2 2026 in Review
Atlas Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 97% in Q2 2026, selling an estimated $1.39M and leaving 169 shares worth $42.9K. The position accounts for ﹤0.01% of the portfolio, ranked #749.
Atlas Capital Advisors first reported a position in JNJ in Q1 2018 and has held it in 33 quarters since. The position peaked at $2.55M in Q2 2019. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Atlas Capital Advisors held 169 shares of Johnson & Johnson worth $42.9K as of Q2 2026.
- Atlas Capital Advisors sold 5,960 Johnson & Johnson shares in Q2 2026, an estimated $1.39M.
- Johnson & Johnson made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q2 2026, its #749 holding.
- Atlas Capital Advisors first reported a position in Johnson & Johnson in Q1 2018 and has held it in 33 quarters since.
- Atlas Capital Advisors's Johnson & Johnson position peaked at $2.55M in Q2 2019.
- 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.